Top Research Reports For Verizon, Goldman Sachs & Kinder Morgan

 | Mar 21, 2019 04:16AM ET

Thursday, March 21, 2019

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Verizon (VZ), Goldman Sachs (GS) and Kinder Morgan (NYSE:KMI). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see

Verizon’s shares have gained +21.6% in the past year, outperforming the Zacks Wireless National industry’s increase of +4% during the same period. The Zacks analyst thinks Verizon remains poised to benefit from the upcoming 5G boom as it aims to launch the 5G Ultra Wideband network in Chicago and Minneapolis in April.

Subsequently, it plans to increase the tally of 5G Ultra Wideband mobility cities to 30 in 2019. It further combines end-to-end fiber network with a large deployment of small cells for improved connectivity and millimeter wave bandwidth. Focus on online content delivery, mobile video and online advertising should also stoke growth.

However, Verizon continues to struggle in a competitive and saturated U.S. wireless market, where spectrum crunch has become a major issue. The wireline division is struggling with persistent losses in access lines owing to competitive pressure from VoIP service providers and aggressive triple-play offerings by cable firms. Verizon is spending heavily on promotion and lucrative discounts, contracting its margins.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Shares of Goldman Sachs have gained +24.8% in the past three months, outperforming the +18.8% gain of the Zacks Investment Banking industry. Further, the company boasts an impressive earnings surprise history, outpacing expectations in all the trailing four quarters.

The Zacks analyst thinks the company’s well-diversified business and focus to capitalize on growth opportunities through strategic moves, along with cost-control efforts, will continue to strengthen the overall business. Also, its focus on digitization initiatives bode well.

However, declining revenues from the Institutional Client Services division remain a hindrance to the bottom-line expansion. Notably, Goldman has been embroiled in the heightened scandal related to the multibillion-dollar 1Malaysia Development Bhd (1MDB), which is a major concern.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Kinder Morgan’s shares have gained +11% in the six months, outperforming the +6% increase of the Zacks Oil & Gas Pipeline industry. The Zacks analyst emphasizes that Kinder Morgan has the largest network of natural gas pipelines in North America that spreads over almost 84,000 miles.

The company’s midstream properties are linked to all the prospective plays in the United States that are rich in natural gas. These extensive networks of natural gas pipelines provide it with stable fee-based revenues. Moreover, the company’s proposed Permian Highway Pipeline (PHP) Project will help the company to cash in on the region’s bottlenecks and improve cash flow visibility.

However, Kinder Morgan has significant exposure to debt with its balance sheet being more levered than the industry. Also, the current backlog of $5.7 billion is significantly lower than the high of $22 billion recorded in 2015, affecting the company’s future cash flows.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Other noteworthy reports we are featuring today include Intuitive Citigroup (C), Eversource Energy (ES) and Stanley Black & Decker (NYSE:SWK).

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?

From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.

This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly

Today's Must Read/h6

Featured Reports/h6

Per the Zacks analyst Eversource's investment to upgrade its transmission and distribution infrastructure and focus on renewable energy generation will drive its performance.

Per the Zacks analyst, solid traction of Stanley Black & Decker's Tools & Storage segment bode well for its growth momentum.

Per the Zacks analyst, Conatus focuses on the development of emricasan for treating fibrosis or cirrhosis caused by NASH.

Per the Zacks analyst, Celldex has several promising early to mid-stage immuno-oncology candidates in its pipeline being developed for several cancer indications.

Per the Zacks analyst, Big 5 Sporting is focused on expanding its store base and introducing technological advancements to boost services.

New Upgrades/h6

Per the Zacks analyst, Annaly's effort to opportunistically grow its credit business in order to diversify the company's investment portfolio will provide more stable returns in the days ahead.

Per the Zacks analyst, Shaw Communications' Wireless business is benefiting from higher subscriber growth and an improvement in average revenue per unit (ARPU).

New Downgrades/h6

Per the Zacks analyst, though Citigroup is working hard on restructuring activities to focus on core operations, litigation burden related to past misconduct and declining fee income persists.

Dull prospects in Cerner's Licensed Software and Subscriptions unit plague the company. The Zacks analyst is also apprehensive about low software bookings anticipated by management in the near term.

Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes